January 17, 2013 from 12pm to 1pm – Eastern Time ZoneJanuary 17 at noon EST
Dr. Bob Spiegel, Chief Medical Offier at PTC Therapeutics will present information about the study design and timeline for the upcoming Phase 3 confirmatory study of ataluren…Organized by PPMD | Type: webinar, ptc, ataluren
June 3, 2014 from 1pm to 2pm – Eastern Time ZoneIn a webinar hosted by United Parent Project Muscular Dystrophy, Robert Spiegel, MD, FACP, chief medical officer of PTC Therapeutics, presented an overview of the positive opinion by the Committee f…Organized by PPMD | Type: webinar, ptc, translarna, ataluren